Inspire Medical Systems (NYSE:INSP – Get Free Report) posted its quarterly earnings data on Monday. The company reported $1.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.74 by $0.41, Zacks reports. Inspire Medical Systems had a net margin of 4.37% and a return on equity of 5.30%.
Inspire Medical Systems Stock Performance
Shares of INSP stock opened at $183.17 on Wednesday. The stock has a market capitalization of $5.49 billion, a P/E ratio of 171.18 and a beta of 1.32. The company has a 50 day moving average price of $189.39 and a 200 day moving average price of $191.39. Inspire Medical Systems has a fifty-two week low of $123.00 and a fifty-two week high of $257.40.
Wall Street Analyst Weigh In
Several equities analysts have issued reports on INSP shares. Robert W. Baird decreased their price objective on shares of Inspire Medical Systems from $252.00 to $248.00 and set an “outperform” rating on the stock in a report on Tuesday. Morgan Stanley decreased their price objective on shares of Inspire Medical Systems from $230.00 to $220.00 and set an “overweight” rating on the stock in a report on Tuesday. Stifel Nicolaus decreased their price objective on shares of Inspire Medical Systems from $200.00 to $190.00 and set a “hold” rating on the stock in a report on Tuesday, January 21st. KeyCorp reissued an “overweight” rating and issued a $234.00 price target (down from $236.00) on shares of Inspire Medical Systems in a research note on Friday, January 24th. Finally, Truist Financial decreased their price target on shares of Inspire Medical Systems from $250.00 to $235.00 and set a “buy” rating on the stock in a research note on Tuesday. Three research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat, Inspire Medical Systems has an average rating of “Moderate Buy” and an average target price of $228.82.
About Inspire Medical Systems
Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.
Featured Articles
- Five stocks we like better than Inspire Medical Systems
- Transportation Stocks Investing
- Shopify Confirms Stock Uptrend, New Highs in Sight
- Most active stocks: Dollar volume vs share volume
- Super Micro Computer’s Stock Is About to Make a Super Big Advance
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Will the Tariff Bump Lead to a Steel Trap?
Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.